Quick Answer
Humacyte, Inc. reported Total Assets of $116.37 million for fiscal year 2025.
Humacyte, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $116.37M | -15.6% |
| 2024 | $137.87M | +7.5% |
| 2023 | $128.22M | -37.2% |
| 2022 | $204.30M | -28.7% |
| 2021 | $286.53M | +168.6% |
| 2020 | $106.69M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $91.51M | -20.3% | -34.1% |
| June 30, 2025 | $138.79M | +0.4% | -14.6% |
| March 31, 2025 | $162.55M | +0.7% | +17.9% |
| December 31, 2024 | $137.87M | +7.5% | +20.1% |
| September 30, 2024 | $114.76M | -23.2% | -17.0% |
| June 30, 2024 | $138.28M | -17.7% | -14.4% |
| March 31, 2024 | $161.47M | -11.8% | +25.9% |
| December 31, 2023 | $128.22M | -37.2% | -14.2% |
- Humacyte, Inc. showed a decrease of -15.6% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Humacyte, Inc.’s total assets has grown by 9.1% (from $106.69 million to $116.37 million).
- The most recent figure is from Humacyte, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: